WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

FDA makes the Draeger VentStar Resus Neo hose removal a Class I recall Control Bionics wins a Class I CE mark for the NeuroStrip muscle sensor Medicare starts paying for Carlsmed Aprevo lumbar fusion under three new codes ABK Biomedical breaks ground on a Missouri plant for its Y90 microspheres Boston Scientific releases the last $8M from Elutia's BioEnvelope sale BlueWind gets a Category I CPT code for subfascial tibial neuromodulation Emboline runs its first US commercial Emboliner cases at Columbia SedMed raises $4M for a toilet lift that runs without power CDRH plans 11 final guidances in FY2027 and puts AI lifecycle management first FDA makes the Draeger VentStar Resus Neo hose removal a Class I recall Control Bionics wins a Class I CE mark for the NeuroStrip muscle sensor Medicare starts paying for Carlsmed Aprevo lumbar fusion under three new codes ABK Biomedical breaks ground on a Missouri plant for its Y90 microspheres Boston Scientific releases the last $8M from Elutia's BioEnvelope sale BlueWind gets a Category I CPT code for subfascial tibial neuromodulation Emboline runs its first US commercial Emboliner cases at Columbia SedMed raises $4M for a toilet lift that runs without power CDRH plans 11 final guidances in FY2027 and puts AI lifecycle management first

Acquisition

Wandercraft buys Ekso Bionics and puts four medical exoskeletons under one owner

MedDevice Startups Staff · 5 days ago · 2 min read · Via Wandercraft release

Wandercraft bought Ekso Bionics and signed and closed the deal on the same day, October 1. Neither side disclosed the price. The seller was ChronoScale Holdings Corporation (Nasdaq: CHRN), which is moving toward cloud AI infrastructure.

Four exoskeletons now sit under one owner. Wandercraft brings Atalante X for clinics and Eve for personal use. Ekso brings EksoNR for clinics and Indego Personal. Atalante X and EksoNR together run in more than 700 rehabilitation centers worldwide. Both platforms hold FDA clearances and CE marks covering stroke, spinal cord injury, multiple sclerosis and acquired brain injury.

Two personal exoskeletons in one portfolio leaves an overlap to resolve. Wandercraft opened Eve sales in September with Medicare code K1007 in hand, which gives it a reimbursement path Indego Personal customers will ask about.

Questions & Answers

How much did Wandercraft pay for Ekso Bionics?

Wandercraft did not disclose the price it paid for Ekso Bionics. The transaction was signed and closed on October 1, 2026.

Who sold Ekso Bionics to Wandercraft?

ChronoScale Holdings Corporation (Nasdaq: CHRN) sold Ekso Bionics to Wandercraft through a subsidiary on October 1, 2026.

Which exoskeletons does Wandercraft own after the Ekso Bionics acquisition?

Wandercraft now owns four: Atalante X and Eve from its own line, plus EksoNR and Indego Personal from Ekso Bionics.

← Back to M&A